Jorge A. Torres, Md, Phd
AeroLeads people directory · profile

Jorge A. Torres, Md, Phd Email & Phone Number

Head of Neurology, Clinical Development: Cell Therapies at Kite Pharma
Location: Boston, Massachusetts, United States 17 work roles 8 schools
1 work email found @alexion.com LinkedIn matched
4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email j****@alexion.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Head of Neurology, Clinical Development: Cell Therapies
Location
Boston, Massachusetts, United States
Company size

Who is Jorge A. Torres, Md, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Jorge A. Torres, Md, Phd is listed as Head of Neurology, Clinical Development: Cell Therapies at Kite Pharma, a company with 3935 employees, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at alexion.com and a matched LinkedIn profile for Jorge A. Torres, Md, Phd.

Jorge A. Torres, Md, Phd previously worked as Senior Director, Early Clinical Development Lead, Neurology & Genomic Medicines at Alexion Pharmaceuticals, Inc. and Director, Translational Medicine, Early Clinical Development Lead at Alexion Pharmaceuticals, Inc.. Jorge A. Torres, Md, Phd holds Anne B Young, M.D., Ph.D, Fellowhsip, Therapeutic Development In Translational Neuroscience from Harvard Medical School - Massachusetts General Hospital.

Company email context

Email format at Kite Pharma

This section adds company-level context without repeating Jorge A. Torres, Md, Phd's masked contact details.

*@alexion.com
68% confidence

AeroLeads found 1 current-domain work email signal for Jorge A. Torres, Md, Phd. Compare company email patterns before reaching out.

Profile bio

About Jorge A. Torres, Md, Phd

Dr. Torres is a board certified, Harvard trained neurologist, physician scientist, with an emphasis in Multiple Sclerosis and Neuroimmunology, and advanced biomarker development in neurodegenerative/regenerative (special emphasis on MRI) for clinical trial endpoints. He has leadership experience in clinical development programs from pre-IND to Phase I-IV, experience in small molecule, antibody, siRNA, and gene therapy across various neurologic indications including rare disease indications and key regulatory interactions with the FDA, EMA, and CDE. He completed his neurology residency and has fellowship training in Multiple Sclerosis and Neuroimmunology in the MGH-BWH-Harvard Medical School programs. He also has neuroscience translational medicine fellowship training via the Biogen-MGH Anne B Young MD PhD fellowship. He completed medical school at the UCLA David Geffen School of Medicine where he spent 5 years conducting translation research in the disease area of Limb Girdle Muscular Dystrophy and prior to that spent 5 years at UCSF conducting basic and translational research in Duchenne Muscular Dystrophy and muscle metabolism. Editor & Chief of Alliance in Mentorship (AIM), founders of MiMentor. @JorgeTorresMD

Listed skills include Research, Cell, Cell Culture, Molecular Biology, and 6 others.

Current workplace

Jorge A. Torres, Md, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Kite Pharma
Kite Pharma
Head of Neurology, Clinical Development: Cell Therapies
Boston, MA, US
Website
Employees
3935
AeroLeads page
17 roles · 8 years

Jorge A. Torres, Md, Phd work experience

A career timeline built from the work history available for this profile.

Head Of Neurology, Clinical Development: Cell Therapies

Boston, MA, US

Senior Director, Early Clinical Development Lead, Neurology & Genomic Medicines

Current

Boston, Massachusetts, US

Senior Medical Director, Clinical Development, Head of Neurology Translational Medicine

Oct 2024 - Present

Director, Translational Medicine, Early Clinical Development Lead

Boston, Massachusetts, US

Medical Director, Translational Medicine, Clinical DevelopmentAlexion Rare Disease Unit, AstraZenecaAs Early Clinical Development Lead, I provide leadership, strategic input and program execution in Early Clinical Development, guiding multiple programs with multiple MOA and modalities (small molecule, large molecule, RNA modalities, Genomic Medicines) with.

Jul 2023 - Oct 2024

Stroke Neurologist And Neurohospitalist

Current

Fort Myers, Florida, US

Neurology clinical care ranging from stroke, TBI, concussion, headache, seizure, neuroinflammatory disorders and general neurology.

Jun 2022 - Present

Medical Director, Clinical Development

Cambridge, MA, US

Feb 2023 - Jul 2023

Associate Medical Director, Clinical Development

Cambridge, MA, US

Clinical Development in Multiple Sclerosis & Immunology Development Unit (MSIDU). Study/Program Lead experience in clinical development in preclinical/pre-IND programs and programs in Phase I-IV, in study design, execution, and analysis.Clinical Development Lead for a marketed asset, responsible for LCM, regional expansion and PMR studies.

Mar 2022 - Feb 2023

Aby, M.D., Ph.D., Neuroscience Translational Medicine Fellow, Clinical Development

Cambridge, MA, US

As a Neuroscience Translational Medicine Fellow, my roles took place in Clinical Development in Multiple Sclerosis & Immunology Development Unit (MSIDU). My main focus was on developing and refining the Biomarker Strategy (Imaging, Fluid, EP etc) and Clinical Development Plan (CDP) for remyelination and neurorepair.

Jul 2021 - Mar 2022

Neurologist And Brain Injury Medicine

Boston, Massachusetts, US

Inpatient brain injury medicine, TBI, stroke and neuro recovery and rehab medicine at Spaulding Rehab Hospital (SRH), Harvard Medical School.

Jun 2020 - Jun 2023

Clinical Imaging Biomarker Post Doctoral Scientist

Charlestown, MA, US

These research activities took place at the Multiple Sclerosis Imaging Laboratory at the MGH Martinos Center, which focused on advance MRI analysis of diffusion tensor imaging (DTI) MRI, resting state functional MRI, structural MRI, and connectomics on 3T and 7T, with the goal of developing and refining biomarkers for early diagnosis and treatment response.

2018 - 2022 ~4 yrs

Clinical And Translational Science Institute (Ctsi) Pathway Researcher

Los Angeles, CA, US

This translational research took place under CTSI pathway at UCLA’s Center for Duchenne Muscular Dystrophy (DMD) with a research emphasis in a mouse model of Limb Girdle Muscular Dystrophy and identified key inflammatory pathway involved in muscle regeneration.

Jul 2013 - Jun 2018

Translational Clinical Research Fellow

San Francisco, California, US

Translational research on mouse model for Duchenne muscular dystrophy (mdx) and immunotherapy. Cell trafficking and molecular immunology.

Aug 2008 - Jul 2013

Research Intern

Buffalo, NY, US

This research focused on the mechanism by which fever-range hyperthermia affects the plasma membrane organization and the threshold of T cell activation.

Jun 2009 - Aug 2009
Team & coworkers

Colleagues at Kite Pharma

Other employees you can reach at kitepharma.com. View company contacts for 3935 employees →

8 education records

Jorge A. Torres, Md, Phd education

Anne B Young, M.D., Ph.D, Fellowhsip, Therapeutic Development In Translational Neuroscience

Harvard Medical School - Massachusetts General Hospital

Fellowship, Multiple Sclerosis And Neuroimmunology

Harvard Medical School - Massachusetts General Hospital

Residency In Neurology, Medicine

Harvard Medical School - Massachusetts General Hospital

Intern Resident Physician, Internal Medicine Residency Program

David Geffen School Of Medicine At Ucla

Doctor Of Medicine (M.D.), Clinical Research Focus In Limb Girdle Muscular Dystrophy

David Geffen School Of Medicine At Ucla

Translational Research Fellowship, Phd, Bioengineering And Therapeutic Sciences; Duchenne Muscular Dystrophy, Brodksy Lab, Phd

University Of California, San Francisco

Bachelor'S Degree, Molecular And Cellular Biology

University Of California, Berkeley

Associate'S Degree, A.A. & A.S.

Riverside City College
FAQ

Frequently asked questions about Jorge A. Torres, Md, Phd

Quick answers generated from the profile data available on this page.

What company does Jorge A. Torres, Md, Phd work for?

Jorge A. Torres, Md, Phd works for Kite Pharma.

What is Jorge A. Torres, Md, Phd's role at Kite Pharma?

Jorge A. Torres, Md, Phd is listed as Head of Neurology, Clinical Development: Cell Therapies at Kite Pharma.

What is Jorge A. Torres, Md, Phd's email address?

AeroLeads has found 1 work email signal at @alexion.com for Jorge A. Torres, Md, Phd at Kite Pharma.

Where is Jorge A. Torres, Md, Phd based?

Jorge A. Torres, Md, Phd is based in Boston, Massachusetts, United States while working with Kite Pharma.

What companies has Jorge A. Torres, Md, Phd worked for?

Jorge A. Torres, Md, Phd has worked for Kite Pharma, Alexion Pharmaceuticals, Inc., Telespecialists, Biogen, and Spaulding Rehabilitation Hospital.

Who are Jorge A. Torres, Md, Phd's colleagues at Kite Pharma?

Jorge A. Torres, Md, Phd's colleagues at Kite Pharma include Thuan Alex Nguyen, Ashley Lentz, Carlos Castillo, Lorna K., and Roy Du.

How can I contact Jorge A. Torres, Md, Phd?

You can use AeroLeads to view verified contact signals for Jorge A. Torres, Md, Phd at Kite Pharma, including work email, phone, and LinkedIn data when available.

What schools did Jorge A. Torres, Md, Phd attend?

Jorge A. Torres, Md, Phd holds Anne B Young, M.D., Ph.D, Fellowhsip, Therapeutic Development In Translational Neuroscience from Harvard Medical School - Massachusetts General Hospital.

What skills is Jorge A. Torres, Md, Phd known for?

Jorge A. Torres, Md, Phd is listed with skills including Research, Cell, Cell Culture, Molecular Biology, Clinical Research, Data Analysis, Medical Research, and Public Speaking.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.